For the Quarter Ending September 2025
North America
• In the USA, the Monocalcium Phosphate Price Index fell by 6.56% quarter-over-quarter, reflecting weak demand.
• The average Monocalcium Phosphate price for the quarter was USD 1400/MT, CFR New York settlements.
• Monocalcium Phosphate Spot Price softened as downstream buyers deferred purchases, leaving suppliers to offer discounts.
• Monocalcium Phosphate Price Forecast shows modest upside as restocking supports procurement in feed and food.
• Monocalcium Phosphate Production Cost Trend was stable with ample feedstock, limiting supplier escalation in offers.
• Monocalcium Phosphate Demand Outlook suggests restocking by feed producers, supporting steady volumes without speculative buying.
• Monocalcium Phosphate Price Index movements reflected high inventories, smooth logistics, and limited domestic purchasing urgency.
• Major exporters operated without disruption; adjusted offers to stimulate demand, but buyer caution constrained recovery.
Why did the price of Monocalcium Phosphate change in September 2025 in North America?
• Demand recovery gradual while inventories remained ample, reducing immediate purchasing urgency and limiting price increases.
• Stable production and feedstock availability kept production cost trend contained, thereby limiting supplier price pressure.
• Smooth logistics and softer export offers allowed importers to source competitively, helping restrain price levels in September.
APAC
• In China, the Monocalcium Phosphate Price Index fell by 4.68% quarter-over-quarter, reflecting weaker export demand.
• The average Monocalcium Phosphate price for the quarter was approximately USD 1256.67/MT as reported officially.
• Monocalcium Phosphate Spot Price tightened amid inventory draws, prompting sellers to lift offers for shipments.
• Monocalcium Phosphate Price Forecast remains bullish as replenishment buying and steady production support near-term firmness.
• Monocalcium Phosphate Production Cost Trend subdued with stable phosphoric acid feedstock and steady plant operations.
• Monocalcium Phosphate Demand Outlook improved due to restocking across feed, food fortification and fertilizer compounders.
• Monocalcium Phosphate Price Index movements reflected balanced supply, reliable logistics and importer re-entry into markets.
• Exporters adjusted offers higher as low downstream inventories and steady orders reduced available spot volumes.
Why did the price of Monocalcium Phosphate change in September 2025 in APAC?
• Renewed purchasing to replenish thin inventories drove stronger demand, tightening supply and supporting higher offers.
• Stable phosphoric acid feedstock and uninterrupted plant operations kept production steady, moderating sharper price spikes.
• Smooth inland logistics and timely port operations allowed exporters to meet orders without delivery delays.
Europe
• In Germany, the Monocalcium Phosphate Price Index fell by 3.66% quarter-over-quarter, reflecting demand normalization recently.
• The average Monocalcium Phosphate price for the quarter was approximately USD 1360/MT, CFR-Hamburg basis.
• Monocalcium Phosphate Spot Price remained stable as import flows balanced consumption without speculative buying activity.
• Monocalcium Phosphate Price Forecast indicates modest gains supported by steady logistical performance in near-term period.
• Monocalcium Phosphate Production Cost Trend shows upward pressure from currency swings and stable origin costs.
• Monocalcium Phosphate Demand Outlook remains constructive as feed and food sectors sustain predictable procurement patterns.
• Price Index movement was tempered by balanced inventories, steady exports and absence of transport disruptions.
• Major supplier operations remained uninterrupted, supporting consistent arrivals and limiting spot price volatility across Germany.
Why did the price of Monocalcium Phosphate change in September 2025 in Europe?
• Lean downstream inventories and renewed procurement drove upward pressure despite steady production from origin markets.
• Euro depreciation increased landed costs, partially offsetting softer export offers and constraining sharper price declines.
• Smooth port and inland logistics supported timely deliveries, preventing panic buying and containing price volatility.
For the Quarter Ending June 2025
North America
• In June 2025, the Monocalcium Phosphate Spot Price rose sharply by 7.09%, reaching USD 1510/MT (CFR New York). This increase in prices was driven by a strong rebound in demand from downstream feed and supplement sectors as buyers rushed to replenish thinning inventories.
• May 2025 recorded a steep 10.48% price decline that reflected a sluggish offtake from the pharmaceutical and medical sectors. It was coupled with ample inventory coverage which led to soft market sentiment and reluctant buying activity.
• In April 2025, the Monocalcium Phosphate Price Index declined by 2.48% as high stock levels and subdued feed sector activity led buyers to defer procurement that contributed to a weak demand base.
• The Monocalcium Phosphate Demand Outlook improved in June, particularly from the animal nutrition and dietary supplement segments, as seasonal feed cycles began to influence bulk buying behaviour.
• Suppliers operated with uninterrupted production throughout Q2, and consistent feedstock availability ensured that the Monocalcium Phosphate Production Cost Trend remained stable to declining, particularly in May due to falling raw material input prices.
• US importers experienced smooth logistics and efficient port handling throughout the quarter, allowing for reliable delivery schedules that amplified the influence of demand on pricing.
• Inventory overhangs in May led to price suppression despite ample product availability, while June's restocking urgency reversed that sentiment rapidly, lifting the Monocalcium Phosphate Spot Price.
• Export pricing dynamics from Asia—particularly China—played a key role in shaping the US market trend, with lower FOB values in April–May translating to cheaper landed costs early in the quarter.
• Why did the price change in July 2025?
With inventories largely replenished in June, and no major policy disruptions anticipated, the Monocalcium Phosphate Price Forecast for July 2025 suggests stable to moderately softening prices in the US, contingent on downstream consumption aligning with expectations.
APAC
• Monocalcium Phosphate Spot Price (FOB Shanghai) increased by 1.60% in June 2025, closing at USD 1270/MT, owing to a rebound in downstream procurement and thin inventories among domestic and international buyers.
• May 2025 saw a steep 12.89% price decline, attributed to oversupply, reduced phosphoric acid prices, and weakened pharma/medical sector demand, which all contributed to a bearish Monocalcium Phosphate Price Index.
• In April 2025, prices rose slightly by 0.70%, tempered by global trade frictions, especially the 145% U.S. tariff, which limited international purchasing volumes and constrained overall price movement.
• The Monocalcium Phosphate Demand Outlook strengthened in June, with feed additives, food fortification, and animal nutrition sectors boosting procurement after a prior month of caution.
• Monocalcium Phosphate Production Cost Trend in China dipped during May due to low phosphoric acid costs and high operational continuity across facilities, allowing manufacturers to offer lower prices temporarily.
• China's domestic and export supply chain performance remained smooth and efficient throughout Q2, facilitating quick response to demand shifts without bottlenecks or cost shocks.
• Exporters responded to June’s rebound by lifting offers, driven by renewed international interest and strategic restocking across Asia and the Middle East.
• Despite subdued pharma demand in May, animal feed and food supplement segments led the recovery, particularly in response to seasonal requirements in APAC consumer markets.
• Why did the price change in July 2025?
With upstream costs starting to stabilize and inventories now more balanced, the Monocalcium Phosphate Price Forecast for APAC July 2025 suggests steady to mildly firm pricing, supported by ongoing restocking in Southeast Asia and South Asia.
Europe
• The Monocalcium Phosphate Spot Price (CFR Hamburg) rose by 3.76% in June 2025, reaching USD 1380/MT, propelled by inventory exhaustion and renewed buying interest from feed and supplement manufacturers.
• A sharp 12.79% price drop in May 2025 was driven by weak procurement from the pharma sector, as buyers held excess inventory and preferred drawing down existing stocks rather than purchasing anew.
• April 2025 saw a marginal 0.65% price dip, reflecting strategic procurement caution amidst smooth supply availability and subdued agricultural demand.
• The Monocalcium Phosphate Demand Outlook improved notably in June, especially from animal feed processors responding to seasonal production cycles and anticipating further price increases.
• Supply-side stability characterized the quarter, with no major logistics issues or policy constraints affecting European imports—this kept the Monocalcium Phosphate Production Cost Trend relatively flat.
• European buyers, especially in Germany, shifted from passive to active procurement in June, primarily due to lean inventory levels following a two-month lull.
• Global FOB pricing from Asia started strengthening in June, and this fed into Europe’s Monocalcium Phosphate Spot Price trajectory, reinforcing the bullish shift.
• The price recovery in June was not driven by speculative activity but rather by fundamental market needs, as downstream sectors prioritized operational continuity.
• Why did the price change in July 2025?
With inventory rebalancing largely achieved and no signs of aggressive seasonal demand, the Monocalcium Phosphate Price Forecast for Europe in July 2025 leans toward moderation or slight softening, unless a raw material or energy cost shock occurs.
For the Quarter Ending March 2025
North America
In the first quarter of 2025 the Monocalcium Phosphate (Monohydrate) prices in North America saw a healthy rise of 5.94% on average. The increase was supported by strong demand from the pharmaceutical and food sectors. The production activity gradually picked up with the seasonal shift from winter to early spring. Several buyers across the region planned procurement in advance in anticipation of better demand in the coming quarter. This led to firm price levels in the entire North American region in the first quarter of 2025.
Tariff regulations remained in place but did not sharply affect the overall trade and prices. The supply situation stayed balanced as producers managed inventories well. Logistics also ran smoothly which allowed consistent movement of goods. Demand from downstream sectors like food processing and nutraceuticals improved as companies prepared for post-winter sales cycles.
Procurement was steady and most buyers restocked to ensure readiness for upcoming consumption. The positive demand and organized supply helped prices move upward in the region. Overall, the North American market remained active and optimistic with a clear upward trend in pricing throughout the quarter.
Asia Pacific
In Asia Pacific, the market for Monocalcium Phosphate (Monohydrate) recorded a modest average price increase of 0.12% during the first quarter of 2025 in comparison to the previous quarter. The region remained generally stable which was supported by seasonal changes and early-year adjustments. The Chinese Lunar New Year, which fell in the early part of the quarter had a slight impact and slowed production activity for a brief period. However, after the holiday, production resumed steadily and helped meet regular demand.
The seasonal transition played a quiet role in supporting production and consumption across the region. Procurement from downstream sectors such as food and beverages remained consistent. While the price rise was not sharp, it reflected balanced market behaviour. Inventories were handled with care and there was no major oversupply. Supply chains operated efficiently in most areas across APAC region. Even though the increase was small, it suggested that overall demand held firm.
The market moved gradually and was driven by practical procurement, regular offtakes and anticipation of the upcoming production cycle. The soft price movement reflected a stable outlook without large fluctuations across the Asia Pacific region during first quarter of 2025.
Europe
In European region the Monocalcium Phosphate (Monohydrate) prices rose by an average of 3.07% during the first quarter of 2025 compared the average prices in previous quarter. The European market remained stable and well-aligned with regional demand. Pharmaceutical and food industries showed improved activity as warmer temperatures arrived which observed increase of demand from end-user sector.
The seasonal shift encouraged higher production which helped to support regular procurement throughout the quarter. Buyers acted early to secure stock in the first quarter in anticipation of stronger usage in the upcoming period and aligned their inventories beforehand. This helped to keep prices elevated in the European region.
Suppliers ensured smooth deliveries, and inventories were well managed. There were no major supply chain hurdles during this period. Downstream demand stayed strong and procurement was paced to meet upcoming needs. The overall market sentiment in Europe remained positive. The steady rise in prices reflected healthy demand conditions and strong logistical support. The upward trend appeared gradual and driven by logical buying behaviour, aligning with improved activity in core application sectors like food and nutraceuticals.
For the Quarter Ending December 2024
North America
The U.S. Monocalcium Phosphate Market in Q4 2024 showcase a Volatile Quarter with a Downward Trend. The fourth quarter of 2024 saw a mixed yet overall downward pricing trend in the U.S. Monocalcium Phosphate market. October witnessed a sharp price surge due to heightened seasonal demand from food and beverage sectors, elevated shipping costs from Asian suppliers, supply chain constraints, and rising raw material prices. Strategic stockpiling and global disruptions in Ukraine and the Middle East compounded supply-side pressures, keeping prices high.
However, in November, prices declined significantly as reduced domestic inventories and lower export prices created arbitrage opportunities. Competitive pricing strategies for the holiday season, coupled with record cargo processing, further eased prices. Demand remained cautious, driven by cost-conscious purchasing rather than strong consumption.
December continued the downward trend, marked by weak demand from pharmaceuticals and oversupply due to elevated inventories and aggressive destocking efforts. Intense competition from Chinese imports added pressure, while new orders fell amid policy uncertainty. Despite the challenges, manufacturers increased employment but scaled back purchasing activity, reflecting subdued market sentiment.
Asia Pacific
Monocalcium Phosphate prices exhibited volatility in Q4 2024, with an overall downward trajectory following an initial surge in October.
In October, prices rose sharply in China due to logistical disruptions caused by severe typhoons, heightened procurement ahead of seasonal demand, and increased pharmaceutical sector consumption. Tight raw material supply, particularly Phosphoric Acid, added to the price pressure, with low inventories and robust buying activity amplifying the upward trend. However, China's economy showed early signs of recovery, with the manufacturing PMI rising to 50.1, though challenges like export declines and rising input costs persisted.
In November, prices declined as producers aggressively reduced inventory ahead of the holiday season, despite steady demand. Oversupply, weak downstream absorption, and geopolitical pressures, such as tariff uncertainties, exacerbated the decline, creating a buyer's market.
Overall, Q4 demonstrated a mixed trend—initial price increases followed by market corrections—driven by structural market conditions, seasonal dynamics, and external factors. The supply-demand imbalance is likely to persist until significant production cuts or demand improvements materialize.
Europe
The Monocalcium Phosphate market in Germany experienced a mixed trend in Q4 2024, starting with a steady price rise but ending with pronounced price declines. In early Q4 2024, Monocalcium Phosphate prices in Germany rose steadily due to constrained supply from key producers, elevated input costs, and strategic price hikes by domestic participants.
Divergent downstream demand, particularly in the pain relief industry, and tight phosphoric acid availability further amplified the bullish sentiment. However, November marked a significant shift as prices entered a downward trajectory due to subdued demand, reduced production costs, and persistent oversupply across the European market. Favorable production conditions, high inventory levels, and competitive buying opportunities pressured prices downward, prompting manufacturers to cut prices aggressively to manage inventories.
Weak downstream demand, cautious procurement, and Euro depreciation sustained the bearish sentiment throughout December. Surplus supply conditions, driven by pre-holiday stockpiling and favorable import dynamics, compounded the softening price trend. Overall, Q4 ended with bearish momentum as suppliers focused on inventory normalization rather than shifts in demand, delaying any prospects for price recovery.
